000			04522nam a2200121Ia 4500
008			220615s9999||||xx |||||||||||||| ||und||
245		0	_aCancer Nanomedicine
546			_aEnglish[eng]
650			_aantibody drug conjugate (ADC)||PD-L1||tumor spheroid disruption||immune modulation||doxorubicin||graphene oxide||adsorption||cathepsin D||cathepsin L||anti-metastatic enzyme cancer therapy||nanoparticles||targeted delivery system||siRNA||osteopontin||mammary carcinoma||mesenchymal stem cells (MSCs)||TAT peptide||PLGA||paclitaxel||nano-engineered MSCs||orthotopic lung tumor model||intracranial glioma||immunotherapy||CPMV||viral nanoparticles||in situ vaccine||albumin nanoparticles||microbubble||ultrasound||theranostics||hepatocellular carcinoma||VX2 tumor||intra-arterial chemotherapy||lung cancer||nanomedicine||clinical status||cancer therapy||breast cancer||cell signaling||active targeting||passive targeting||EPR effect||oncogenes||nanoparticle||drug delivery||ligand||tumor targeting||biodistribution||Mesoporous silica nanoparticle||drug delivery system||target treatment||lanthanide metal||hyaluronic acid||hyaluronidase||drug combination||everolimus||dual-targeting||magnetic nanoparticles||monoclonal antibodies||nanostructured lipid carrier||platelet membrane||biomimicry||plasmonic photothermal therapy||gold nanorods||surgery||bleeding||dogs||cats||stimuli-responsive||DOX||SN38||CSCs||single-walled carbon nanotubes||chirality separation||NASH||drug-gene delivery||near IR hyperspectral imaging||plasmonics||copper||VEGF||glioblastoma||differentiated neuroblastoma||peptidomimetics||real-time quantitative polymerase chain reaction (qPCR)||actin||combinatorial therapy||anticancer and antibacterial activity||temoporfin||drug-in-cyclodextrin-in-liposome||hybrid nanoparticles||multicellular tumor spheroids||cyclodextrins||photodynamic therapy article||yet reasonably common within the subject discipline||antitumor strategy||biomimetic core–shell nanoparticles||NK cell-derived exosomes||folate receptor||albumin nanoparticle||microfluidic||cabazitaxel||polydopamine nanoparticles||size||cytotoxicity||iron affinity||FA-DABA-SMA||self-assembly||oncogenic proteins||intracellular disruption||folic receptor alpha||pancreatic cancer||parvifloron D||albumin||erlotinib||photodynamic therapy||lipid nanoparticles||tumor vectorization||verteporfin||ovarian carcinomatosis||spheroids||integrin||RGD peptide||cancer diagnosis||radiotherapy||hyperthermia therapy||biomimetic||nanocarrier||membrane-wrapped||cancer||targeted delivery||photothermal therapy||imaging||cancer nanomedicine||tumor microenvironment||nano–bio interactions||clinical translation||magnetic nanowires||magnetic hyperthermia||magnetic actuation||magnetic drug targeting||titanate nanotubes||gold nanoparticles||vectorization||colloidal stability||docetaxel||prostate cancer||mangiferin||anti-topoisomerase activity||extracellular vesicles||exosomes||chemico-physical functionalization||loading||translational medicine||nanotechnology: bioengineering||anacardic acid||mitoxantrone||targeted drug delivery||liposomes||melanoma||apoptosis||ascorbic acid||angiogenesis||epithelial-to-mesenchymal transition||hypoxia||immunosuppression||metabolism||nanotherapeutics||tumour microenvironment||DNA origami||liposome||remote loading||acute toxicity||organoids||magnetic silica-coated iron oxide nanochains||photothermal treatment||hyperthermia||collagen||cellular microenvironment||lymphadenectomy||magnetometer||sentinel lymph node dissection||SPION||superparamagnetic iron oxide nanoparticles||Vδ2 T cells||zoledronic acid||polymeric nanoconstruct||anti-tumor immunity||colorectal carcinoma||β-cyclodextrin nanosponges||BALB-neuT mice||brain tumours||glioma||blood brain barrier||polymeric nanoparticles||PEGylation||dioleoylphosphatidylethanolamine||poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer||folate||oxidation-sensitive release||cellular interaction||in vitro anti-cancer activity||triple negative breast cancer||organotin||mesoporous silica nanoparticles||MDA-MB-231||theranostic nanomaterials||nanobiotechnology||molecular imaging||nanosystems||nanomicelles||ovarian cancer||tumour targeting||chemotherapeutics||riboflavin||vitamin B2||nanomedicines||secondary structure||mixed micelle||pH responsive||targeted therapy||anti-cancer||shear stress||flow||in vitro||therapeutics||diagnostics||Immunotherapy
700			_aHoskins, Clare
856			_uhttps://mdpi.com/books/pdfview/book/2846
942			_cEB
999			_c17637 _d17637